PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search

Search

Reset

BNF Chapter

BNF Paragraph

Please select a BNF Chapter.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : E

Records returned : 100 (on 24 Nov 2024 at 00:17:45).

Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
07.02.02
Econazole nitrate
Candidiasis
Non Formulary
Formulations :
  • Pessaries
  • Vaginal cream
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
Eculizumab
No Information Returned
02.08.02
Edoxaban
Atrial fibrillation
Green (see narrative)
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
02.08.02
Edoxaban
Deep Vein Thrombosis (DVT) / Pulmonary Embolism (PE)
Blue
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
NICE
Important
Specialist initiation and at least one month supply before transfer to primary care. Reserved for use where apixaban / rivaroxaban are not suitable
10.02.01
Edrophonium chloride
Myasthenia gravis
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Tensilon test for diagnosis
Efalizumab
No Information Returned
05.03.01
Efavirenz
HIV infection
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
NHSE
Important
Restricted Antimicrobial - requires GUM Specialist approval
Efavirenz/emtricitabine/tenofovir disoproxil
No Information Returned
Eflornithine monohydrate chloride
No Information Returned
05.03.03
Elbasvir/grazoprevir
Hepatitis C
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
R
SA
NHSE
NICE
04.07.04
Eletriptan
Migraine (acute)
Green (see narrative)
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Not 1st line. Generic sumatriptan, naratriptan, rizatripan, zolmitriptan are preferred.
Eliglustat
No Information Returned
Elosulfase alfa
No Information Returned
09.01.04
Eltrombopag
Immune thrombocytopenia
Red
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
09.01.04
Eltrombopag
Immune thrombocytopenia
See Below
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Eluxadoline
No Information Returned
Elvitegravir
No Information Returned
Emedastine
No Information Returned
Emollient bath and shower preparations
No Information Returned
06.01.02
Empagliflozin
Chronic Kidney Disease
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
Important
If a patient with diabetes were on insulin and on multiple other treatments, a discussion with the specialist team may be prudent prior to Empagliflozin initiation.
06.01.02
Empagliflozin
Heart failure
Blue
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
Empagliflozin/linagliptin
No Information Returned
Empagliflozin/metformin
No Information Returned
05.03.01
Emtricitabine
HIV infection
Red
Formulations :
  • Capsules
  • Oral solution
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
NHSE
Important
Restricted Antimicrobial - requires GUM Specialist approval
05.03.01
Emtricitabine and tenofovir alafenamide
HIV infection
Red
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
NHSE
Important
Restricted Antimicrobial - requires GUM Specialist approval
05.03.01
Emtricitabine and tenofovir disoproxil
HIV infection
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
NHSE
Important
Restricted Antimicrobial - requires GUM Specialist approval
05.03.01
Emtricitabine and tenofovir disoproxil
Pre-exposure prophylaxis of HIV-1 infection
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
NHSE
Important
Pre-exposure prophylaxis (PrEP) is available through Sexual Health clinics for people at risk. Use as recommended by BHIVA/BASHH guidelines
05.03.01
Emtricitabine and tenofovir disoproxil
POST-exposure prophylaxis of HIV-1 infection
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
NHSE
Important
For post-exposure prophylaxis (e.g. needlestick injuries), follow your organisation's protocols for referral and access. Use as recommended by BHIVA/BASHH guidelines.
Emulsifying wax
No Information Returned
02.05.05
Enalapril maleate
Heart failure
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
02.05.05
Enalapril maleate
Hypertension
Green (see narrative)
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
Important
Preferred ACE inhibitor during breastfeeding (where an ACE inhibitor is appropriate)
02.05.05
Enalapril maleate
Heart failure (children)
N/A
Formulations :
  • Oro-dispersible
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD2
02.05.05
Enalapril maleate
Heart failure
Non Formulary
Formulations :
  • Oro-dispersible
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Only licensed for use in children.
Enalapril maleate with diuretic
No Information Returned
Encorafenib
No Information Returned
Enfuvirtide
No Information Returned
02.08.01
Enoxaparin
VTE prophylaxis
Green
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Prescribe by brand. RSCH / SASH = Inhixa. ASPH = Clexane
02.08.01
Enoxaparin
VTE treatment in patients unable to take oral anticoagulants
Blue
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Prescribe by brand. RSCH / SASH = Inhixa. ASPH = Clexane. Specialist initiation and at least one month supply before transfer to primary care (excluding obstetric and cancer patients)
02.08.01
Enoxaparin
Pre-operative / bridging therapy
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Prescribe by brand. RSCH / SASH = Inhixa. ASPH = Clexane
02.08.01
Enoxaparin
VTE prevention post hip/knee replacement
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Prescribe by brand. RSCH / SASH = Inhixa. ASPH = Clexane
02.08.01
Enoxaparin
VTE treatment in pregnancy
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Un
Important
Off-label use. Prescribe by brand: RSFT and SASH = Inhixa ASPH = Clexane
02.01.02
Enoximone
Heart failure
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
04.09.01
Entacapone
Parkinson's disease
Blue
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
NICE
Important
Preferred
Preferred COMT inhibitor
05.03.03
Entecavir
Hepatitis B
Red
Formulations :
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
R
NHSE
NICE
Important
RESTRICTED - requires Hepatologist Specialist approval
Enteral nutrition
No Information Returned
Enzalutamide
No Information Returned
02.07.02
Ephedrine hydrochloride
Hypotension
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Hypotentsion reversal in spinal or epidural anaesthesia
Ephedrine hydrochloride/dextromethorphan hydrobromide
No Information Returned
Ephedrine hydrochloride/ipecacuanha
No Information Returned
Ephedrine sulfate
No Information Returned
Epinastine hydrochloride
No Information Returned
Epirubicin hydrochloride
No Information Returned
02.02.03
Eplerenone
Heart failure
Blue
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Initiation restricted to cardiology. Transfer to primary care only after initiation and at least the first month supply from the specialist.
Epoetin alfa
No Information Returned
Epoetin beta
No Information Returned
Epoetin delta
No Information Returned
Epoetin theta
No Information Returned
Epoetin zeta
No Information Returned
Epoprostenol sodium
No Information Returned
02.05.05
Eprosartan
Hypertension
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
02.09.00
Eptifibatide
Acute coronary syndrome
Non Formulary
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
03.07.00
Erdosteine
Reduction of sputum viscosity
Non Formulary
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
Un
Important
Not licensed for this indication - refer to guidelines for alternatives
04.07.04
Erenumab
Migraine (prevention)
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
ICB
BlueTeq
NICE
Preferred
Ergocalciferol
No Information Returned
07.01.01
Ergometrine maleate
Uterine atony
Red
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
07.01.01
Ergometrine with oxytocin
Uterine atony
Red
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Ergotamine tartrate
No Information Returned
Eribulin
No Information Returned
Erlotinib
No Information Returned
05.01.02
05.01.07
Ertapenem sodium
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
Ertugliflozin
No Information Returned
05.01.05
11.03.01
Erythromycin
Bacterial infection
Green
Formulations :
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. Follow local guidelines on the use of antimicrobials.
05.01.05
11.03.01
Erythromycin
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Follow local guidelines on the use of antimicrobials.
Erythromycin ethylsuccinate
No Information Returned
Erythromycin lactobionate
No Information Returned
Erythromycin stearate
No Information Returned
Escitalopram
No Information Returned
Esketamine hydrochloride
No Information Returned
04.08.01
Eslicarbazepine acetate
Epilepsy
Amber
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Only when 1st-line and 1st-line adjunctive agents have been unsuccessful
01.03.05
Esomeprazole
Acid Suppression (Children)
Green (see narrative)
Formulations :
  • Granules
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Branded Nexium granules for children/infants with enteral feeding tubes (6Fr or larger). Off-label use in infants under 1 year. Generic granules 3rd line in children/infants under 1 year without an NG tube. Refer to PPI algorithm for details.
01.03.05
Esomeprazole
Acid suppression (Adults)
Green (see narrative)
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Lansoprazole capsules are the preferred option. Esomeprazole 40mg restricted to short-term use or for Zollinger-Ellison syndrome.
01.03.05
Esomeprazole
Acid suppression (Adults)
Green (see narrative)
Formulations :
  • Granules
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Lansoprazole oro-dispersible 1st-line. Esomeprazole is 3rd-line. Restricted to patients with swallowing difficulties or with large bore enteral feeding tube when other options are not clinically appropriate. Do not use in tubes less than 6F.
01.03.05
Esomeprazole
Acid suppression (Adults)
Non Formulary
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
06.04.01
07.02.01
Estradiol
Vaginal atrophy
Green
Formulations :
  • Vaginal tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Prescribe 10mcg vaginal tablets generically
06.04.01
07.02.01
Estradiol
Vaginal atrophy
Green
Formulations :
  • Vaginal ring
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
06.04.01
07.02.01
Estradiol
Menopausal disorders
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Preferred
Elleste Solo tablets - 1st line
06.04.01
07.02.01
Estradiol
Menopausal disorders
Green
Formulations :
  • Patches
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Estradiol patches 2nd line to tablets. No preferred patch recommendation has been made due to current stock shortages (Estraderm, Estradot, Evorel, FemSeven, Progynova TS)
06.04.01
07.02.01
Estradiol
Menopausal disorders
Green
Formulations :
  • Spray
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Lenzetto spray. Caution with higher than licensed doses.
06.04.01
07.02.01
Estradiol
Menopausal disorders
Green (see narrative)
Formulations :
  • Gel
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Oestrogel is the preferred gel option. Sandrena is an alternative option.
06.04.01
07.02.01
Estradiol
Menopausal disorders
Green (see narrative)
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Progynova and Zumenon tablets NOT 1st line. Only prescribe where Elleste Solo tablets are unavailable.
06.04.01
07.02.01
Estradiol
Transgender Health - adults
Amber
Formulations :
  • Gel
  • Patches
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Un
06.04.01
07.02.01
Estradiol
Transgender Health - Children & Young People
Amber
Formulations :
  • Patches
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Un
Estradiol and estriol with progestogen
No Information Returned
Estradiol and nomegestrol
No Information Returned
Estradiol valandestradiol valerate with dienogest
No Information Returned
Estradiol valerate
No Information Returned
Estradiol with cyproterone acetate
No Information Returned
Estradiol with progestogen
No Information Returned
Estradiol, estriol and estrone
No Information Returned
Estramustine phosphate
No Information Returned
06.04.01
07.02.01
Estriol
Vaginal atrophy
Green
Formulations :
  • Vaginal cream
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Estriol vaginal cream 0.1%
06.04.01
07.02.01
Estriol
Vaginal atrophy
Non Formulary
Formulations :
  • Vaginal gel
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Blissel vaginal gel is non-formulary
06.04.01
07.02.01
Estriol
Vaginal atrophy
Non Formulary
Formulations :
  • Vaginal cream
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Estriol vaginal cream 0.01% is non-formulary
06.04.01
07.02.01
Estriol
Vaginal atrophy
Non Formulary
Formulations :
  • Vaginal tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Estriol 500mcg vaginal tablets are non-formulary.
06.04.01
07.02.01
Estriol
Vaginal atrophy
Non Formulary
Formulations :
  • Pessaries
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Estriol pessaries (Imvaggis) are non-formulary.
Estropipate
No Information Returned
02.11.00
Etamsylate
Menorrhagia
Red
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
U
Important
Unlicensed. Short term use for menorrhagic blood loss.
10.01.03
13.05.02
13.05.03
Etanercept
Psoriatic arthritis
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
ICB
BlueTeq
NICE
10.01.03
13.05.02
13.05.03
Etanercept
Rheumatoid arthritis
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
ICB
BlueTeq
NICE
10.01.03
13.05.02
13.05.03
Etanercept
Juvenile idiopathic arthritis (adults)
Red
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
Un
ICB
BlueTeq
NICE
Important
Prescribe by brand. ICB commissioned in patients after 18 years of age
10.01.03
13.05.02
13.05.03
Etanercept
Juvenile idiopathic arthritis (children)
Red
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
Un
NHSE
BlueTeq
NICE
Important
Prescribe by brand. NHSE commissioned in patients under 18 years of age
10.01.03
13.05.02
13.05.03
Etanercept
Ankylosing spondylitis
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
ICB
BlueTeq
NICE
10.01.03
13.05.02
13.05.03
Etanercept
Non-radiographic axial spondyloarthritis
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
ICB
BlueTeq
NICE
10.01.03
13.05.02
13.05.03
Etanercept
Psoriasis
Red
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
ICB
BlueTeq
NICE
05.01.09
Ethambutol hydrochloride
Tuberculosis
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Ethanolamine oleate
No Information Returned
06.04.01
Ethinylestradiol
Transgender Health - adults
Amber
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Un
Ethionamide
No Information Returned
04.08.01
Ethosuximide
Epilepsy
Blue
Formulations :
  • Capsules
  • Oral solution
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
For absence, atypical and myoclonic seizures
Etidronate disodium
No Information Returned
Etilefrine hydrochloride
No Information Returned
10.01.01
Etodolac
Pain & inflammation - musculoskeletal
Non Formulary
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
Etomidate
No Information Returned
Etonogestrel
No Information Returned
Etonogestrel/ethinylestradiol
No Information Returned
Etoposide
No Information Returned
10.01.01
10.01.04
Etoricoxib
Hyperuricaemia and Gout
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Acute gout, gouty arthritis
10.01.01
10.01.04
Etoricoxib
Pain & inflammation - musculoskeletal
Green (see narrative)
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
2nd line COXX II except for gouty arthritis where etoricoxib is the preferred COX II
Etravirine
No Information Returned
Etynodiol diacetate
No Information Returned
Everolimus
No Information Returned
02.12.00
Evolocumab
Lipid modification
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
Important
Restricted to lipidologists only for heterozygous familial and non-familial hypercholesterolaemia.
02.12.00
Evolocumab
Homozygous familial hypercholesterolaemia
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NHSE
Important
NHSE Specialist Commissioned centres only
Exemestane
No Information Returned
Exenatide
No Information Returned
02.12.00
Ezetimibe
Lipid modification
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
 

For information about the icons and status values within this site, please refer to the keys below.

Icon/Links Key

NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq
BlueTeq form to be completed
NICE
NICE

Traffic Light Status Key

Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Black
Now referred to as "Non Formulary" but some BLACK drugs remain pending review. Not recommended for use in any health setting across Surrey and NW Sussex health economy.
Amber Star
Now referred to as "Blue" but some Amber Star drugs remain pending review. Prescribing initiated and stabliised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across Surrey and NW Sussex health economy. (Formerly BLACK traffic light status)
See Below
Please add a description.
N/A
Please add a description.
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green - Black
Now referred to as "Do not initiate in new patients" but some GREEN/BLACK drugs remain pending review. These drugs are NOT for new initiations (BLACK, (now referred to as Non Formulary)) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required.
See narrative
See narrative - is applied in instances where there may be more than one traffic light status for a drug. This occurs when the traffic light status may differ between specific cohorts of patients e.g. those of childbearing potential and those who are not (in the case of sodium valproate)
Do not initiate in new patients
These drugs are NOT for new initiations (Non Formulary) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required. (Formerly GREEN/BLACK traffic light status)
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More